2,300 records totalling $103,530,599,540.09 CAD, from official Government of Canada open data.
What Parliament authorised this organization to spend versus what it actually spent, across all its votes. Source: Public Accounts of Canada (via GC InfoBase). This covers the organization's entire budget, not just the grants and contracts listed below.
| Fiscal year | Authorised | Spent | Used |
|---|---|---|---|
| 2024-2025 | $9,559,576,173 | $8,749,465,180 | 91.5% |
| 2023-2024 | $7,537,514,084 | $6,842,293,218 | 90.8% |
| 2022-2023 | $5,616,743,295 | $4,322,308,189 | 77.0% |
| 2021-2022 | $9,448,845,846 | $6,044,784,701 | 64.0% |
| 2020-2021 | $3,735,326,837 | $3,116,652,943 | 83.4% |
| 2019-2020 | $2,736,768,468 | $2,675,389,069 | 97.8% |
| 2018-2019 | $2,425,447,582 | $2,369,749,252 | 97.7% |
| 2017-2018 | $3,725,634,067 | $3,491,052,712 | 93.7% |
| 2016-2017 | $4,268,411,137 | $4,153,217,124 | 97.3% |
| 2015-2016 | $3,931,578,293 | $3,881,132,152 | 98.7% |
Every department sets measurable performance targets and reports against them. Source: Departmental Results Reports via GC InfoBase — the department's own self-reported scorecard.
34
of 64 targets met
7
targets not met
23
not yet measurable or unavailable
Percentage of youth (grades 10-12) who report frequent (daily to weekly) cannabis use in the past 30 days
Target: — · Actual: 10.5
Percentage of domestic consumer product recalls communicated to Canadians in a timely manner
Target: — · Actual: 87.0
Percentage of pre-market pesticide submission reviews that are completed within service standards
Target: — · Actual: 88.0
Percentage of pharmacies inspected that are deemed to be compliant with the Controlled Drugs and Substances Act and its Regulations
Target: — · Actual: 69.0
Percentage of people in Canada surveyed who are knowledgeable about radon
Target: — · Actual: 66.0
To enhance health services access for French and English linguistic minority communities in Canada and improve the accessibility, quality, sustainability and accountability of Canada’s health care sys...
To support the federal government’s commitment to maintain a strong and effective publicly funded health care system through investments in emerging and demonstrated innovations in priority areas, suc...
Not Available
Not a Project (Mandated or Core Funding)
To enhance health services access for French and English linguistic minority communities in Canada and improve the accessibility, quality, sustainability and accountability of Canada’s health care sys...
To support the federal government’s commitment to maintain a strong and effective publicly funded health care system through investments in emerging and demonstrated innovations in priority areas, suc...
The Ministère de la Santé et des Services sociaux (MSSS) manages the SUAP funds in the province of Québec. L' Institut national de santé publique du Québec and l'Institut universitaire sur les dépenda...
Not a Project (Mandated or Core Funding)
To enhance health services access for French and English linguistic minority communities in Canada and improve the accessibility, quality, sustainability and accountability of Canada’s health care sys...
To enhance health services access for French and English linguistic minority communities in Canada and improve the accessibility, quality, sustainability and accountability of Canada’s health care sys...
To support the federal government’s commitment to maintain a strong and effective publicly funded health care system through investments in emerging and demonstrated innovations in priority areas, suc...
Not a Project (Mandated or Core Funding)
Not a Project (Mandated or Core Funding)
Not a Project (Mandated or Core Funding)
To enhance health services access for French and English linguistic minority communities in Canada and improve the accessibility, quality, sustainability and accountability of Canada’s health care sys...
To support the federal government’s commitment to maintain a strong and effective publicly funded health care system through investments in emerging and demonstrated innovations in priority areas, suc...
Not Available
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and serv...
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and serv...
Not a Project (Mandated or Core Funding)
Not a Project (Mandated or Core Funding)
This initiative provided pharmaceutical-grade prescribed alternatives (safer supply) medications (opioid/OAT/stimulant) to address the overdose risk posed by the toxic illegal drug market. It included...
Helped reduce harms related to the toxic illegal drug supply by providing prescribed alternatives (safer supply) opioids to patients with opioid use disorder during the pandemic and beyond.
Helped reduce harms related to the toxic illegal drug supply by providing prescribed alternatives (safer supply) opioids to patients with opioid use disorder during the pandemic and beyond.
Not a Project (Mandated or Core Funding)